SCHEMBL8957307

SCHEMBL8957307

Cc1ccccc1CCO[N+](=O)[O-]

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.46
HSD17B10 Q99714 1/20 0.41
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
KMT2A Q03164 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
PTGS2 P35354 5/20 0.39
ALDH1A1 P00352 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
MAPT P10636 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
HTT P42858 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
PTGS1 P23219 2/20 0.37
DAO P14920 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8957406 0.80 ALDH1A1 (0.56) HSD17B10NPC1RAB9AALDH1A1MAPT
SCHEMBL8957420 0.76 NQO2 (0.46) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL28730038 0.75 TAAR1 (0.54) TAAR1KMT2APTGS2PTGS1DAO
SCHEMBL9181973 0.74 TAAR1 (0.58) TAAR1KMT2APTGS2PTGS1DAO
SCHEMBL9483438 0.73 PTGS2 (0.42) HSD17B10MEN1NPC1KMT2ASMN1; SMN2
SCHEMBL1491311 0.73 CA1 (0.46) NPC1RAB9APTGS2TDP1PTGS1
SCHEMBL3589537 0.73 TAAR1 (0.47) TAAR1MEN1KMT2APTGS2ALDH1A1
SCHEMBL8816288 0.72 TAAR1 (0.56) TAAR1MEN1KMT2APTGS2ALDH1A1
SCHEMBL28347254 0.72 PTGS2 (0.37) NPC1PTGS2ALDH1A1PTGS1ESR2
SCHEMBL9356427 0.71 TAAR1 (0.46) TAAR1HSD17B10MEN1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0689435-A1 USE OF SUBSTITUTED ALKYL NITRATES FOR THE TREATMENT OF PATHOLOGICALLY INCREASED INTRA-OCULAR PRESSURE BYK NEDERLAND BV (NL) 1996-01-03 EP claimed
WO-1994021248-A1 USE OF SUBSTITUTED ALKYL NITRATES FOR THE TREATMENT OF PATHOLOGICALLY INCREASED INTRA-OCULAR PRESSURE BYK NEDERLAND BV (NL) 1994-09-29 WO claimed
EP-0689435-A1 USE OF SUBSTITUTED ALKYL NITRATES FOR THE TREATMENT OF PATHOLOGICALLY INCREASED INTRA-OCULAR PRESSURE BYK NEDERLAND BV (NL) 1996-01-03 EP disclosed
WO-1994021248-A1 USE OF SUBSTITUTED ALKYL NITRATES FOR THE TREATMENT OF PATHOLOGICALLY INCREASED INTRA-OCULAR PRESSURE BYK NEDERLAND BV (NL) 1994-09-29 WO disclosed